Coriolis Pharma Research GmbH
Coriolis Pharma Research GmbH is a Private limited company (Ltd.) registered in Germany under HRB 186849 München, and its current status with Handelsregister (Commercial Register) is active. Its registered address on file is Martinsried, Germany. 5 shareholders are on record for Coriolis Pharma Research GmbH, including at least one natural person recorded as a direct holder; the filing carries no beneficial-ownership flag, so that holder is noted here as a recorded shareholder rather than a confirmed ultimate beneficial owner (UBO). This profile is sourced directly from Handelsregister (Commercial Register) and was last updated on 24 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Five shareholders are currently on record for Coriolis Pharma Research GmbH, held on the Gesellschafterliste (shareholder list), filed under §40 of the GmbHG.
The largest of these is Leitzach GmbH, holding 30% — the largest recorded stake — followed by Thomas Wiggenhorn at 30%; the remaining 3 shareholders shown hold smaller stakes.
3 shareholders shown are companies, so the ownership chain continues above this level for those holdings; the other 2 are recorded as direct individual holders, though the record carries no UBO/PSC flag confirming beneficial-owner status.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Leitzach GmbH | 30% | Handelsregister (Commercial Register) | |
| Thomas Wiggenhorn | 30% | Handelsregister (Commercial Register) | |
| Leitzach GmbH | 30% | Handelsregister (Commercial Register) | |
| Prof. Dr. Wolfgang Frieß | 5% | Handelsregister (Commercial Register) | |
| Coriolis Pharma Research GmbH | 5% | Handelsregister (Commercial Register) |
Officers
5
Three of the 5 officer records shown for Coriolis Pharma Research GmbH are current appointments, filed with Handelsregister (Commercial Register). Silvia Steyrer-Gruber (appointed 2022-08-18) serves as Geschäftsführer (managing director); André Steingröver (appointed 2021-12-07) and Frank Schaubhut (appointed 2021-12-07) both serve as Officer. The remaining 2 records shown (Thomas Wiggenhorn and Michael Wiggenhorn) are former appointments that have since been resigned.
The register reports 8 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at Coriolis Pharma Research GmbH sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
Coriolis Pharma Research GmbH sits 4 levels below its ultimate parent, Tigra Topco S.a r.l., registered in Luxembourg. The full chain up to Tigra Topco S.a r.l. is derived by walking shareholder filings across jurisdictions; no link in it is independently corroborated by Coriolis Pharma Research GmbH's own shareholder record.
Tigra Topco S.a r.l.
Luxembourg
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns Coriolis Pharma Research GmbH?
Five shareholders are currently on record for Coriolis Pharma Research GmbH, held on the Gesellschafterliste (shareholder list), filed under §40 of the GmbHG. The largest of these is Leitzach GmbH, holding 30% — the largest recorded stake — followed by Thomas Wiggenhorn at 30%; the remaining 3 shareholders shown hold smaller stakes. 3 shareholders shown are companies, so the ownership chain continues above this level for those holdings; the other 2 are recorded as direct individual holders, though the record carries no UBO/PSC flag confirming beneficial-owner status.
Who is Coriolis Pharma Research GmbH's UBO (Ultimate Beneficial Owner)?
At least one shareholder recorded for Coriolis Pharma Research GmbH is a natural person. The record carries no dedicated UBO/PSC flag, so that holder is stated here as a recorded shareholder rather than a confirmed Ultimate Beneficial Owner (UBO).
How many shareholders does Coriolis Pharma Research GmbH have on record?
5 shareholders are shown on record for Coriolis Pharma Research GmbH.
What is Coriolis Pharma Research GmbH's company registration number?
Coriolis Pharma Research GmbH's registration number is HRB 186849 München, filed with Handelsregister (Commercial Register) in Germany. Its current status on the register is active.
Is Coriolis Pharma Research GmbH still an active company?
Coriolis Pharma Research GmbH's status on Handelsregister (Commercial Register) is listed as active.
What is Coriolis Pharma Research GmbH's registered address?
The registered address on file for Coriolis Pharma Research GmbH is Martinsried, Germany.
Who are the officers/directors of Coriolis Pharma Research GmbH?
Three of the 5 officer records shown for Coriolis Pharma Research GmbH are current appointments, filed with Handelsregister (Commercial Register). Silvia Steyrer-Gruber (appointed 2022-08-18) serves as Geschäftsführer (managing director); André Steingröver (appointed 2021-12-07) and Frank Schaubhut (appointed 2021-12-07) both serve as Officer. The remaining 2 records shown (Thomas Wiggenhorn and Michael Wiggenhorn) are former appointments that have since been resigned. Management authority at Coriolis Pharma Research GmbH sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does Coriolis Pharma Research GmbH have a parent company or subsidiaries?
Coriolis Pharma Research GmbH sits 4 levels below its ultimate parent, Tigra Topco S.a r.l., registered in Luxembourg.
Can Zavia monitor changes to Coriolis Pharma Research GmbH's ownership over time?
This profile reflects a point-in-time snapshot from Handelsregister (Commercial Register). Zavia's monitoring API can track changes to Coriolis Pharma Research GmbH's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Coriolis Pharma Research GmbH's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Germany, so records like Coriolis Pharma Research GmbH's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Handelsregister (Commercial Register) and was last synced on 24 October 2026.